MD3244G2 - Metodă de apreciere a agresivităţii cancerului endometrial - Google Patents

Metodă de apreciere a agresivităţii cancerului endometrial

Info

Publication number
MD3244G2
MD3244G2 MDA20060139A MD20060139A MD3244G2 MD 3244 G2 MD3244 G2 MD 3244G2 MD A20060139 A MDA20060139 A MD A20060139A MD 20060139 A MD20060139 A MD 20060139A MD 3244 G2 MD3244 G2 MD 3244G2
Authority
MD
Moldova
Prior art keywords
aggressivity
endometrial cancer
units
determined
determining
Prior art date
Application number
MDA20060139A
Other languages
English (en)
Russian (ru)
Other versions
MD3244F1 (ro
Inventor
Думитру СОФРОНИ
Лилиан ГУЦУ
Катйа ТЕННЕР
Анатол ЧЕРНЫЙ
Корина КАРДАНЮК
Михаил ТОДИРАШ
Майкл БАДЕР
Original Assignee
Общественное Медико-Санитарное Учреждение Онкологический Институт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общественное Медико-Санитарное Учреждение Онкологический Институт filed Critical Общественное Медико-Санитарное Учреждение Онкологический Институт
Priority to MDA20060139A priority Critical patent/MD3244G2/ro
Publication of MD3244F1 publication Critical patent/MD3244F1/ro
Publication of MD3244G2 publication Critical patent/MD3244G2/ro

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la medicină, în special la oncologie şi poate fi utilizată pentru aprecierea precoce neinvazivă a agresivităţii cancerului endometrial.Esenţa invenţiei constă în aceea că se determină în ţesuturile endometrial şi miometrial nivelul de ARN mesager pentru triptofanhidroxilaza-1, şi în cazul, în care nivelul constituie 0…15 unităţi se determină o agresivitate majoră, 16…400 unităţi - o agresivitate medie, 400 unităţi şi mai mult se determină o agresivitate scăzută a cancerului endometrial.
MDA20060139A 2006-05-15 2006-05-15 Metodă de apreciere a agresivităţii cancerului endometrial MD3244G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20060139A MD3244G2 (ro) 2006-05-15 2006-05-15 Metodă de apreciere a agresivităţii cancerului endometrial

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20060139A MD3244G2 (ro) 2006-05-15 2006-05-15 Metodă de apreciere a agresivităţii cancerului endometrial

Publications (2)

Publication Number Publication Date
MD3244F1 MD3244F1 (ro) 2007-02-28
MD3244G2 true MD3244G2 (ro) 2007-12-31

Family

ID=37845198

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060139A MD3244G2 (ro) 2006-05-15 2006-05-15 Metodă de apreciere a agresivităţii cancerului endometrial

Country Status (1)

Country Link
MD (1) MD3244G2 (ro)

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Chen+G%22%5BAuthor%5D>., Zhang B *
<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Zhang+B%22%5BAuthor%5D>. Expression of vascular *
endothelial growth factor and its receptors in endometrial carcinoma. Zhonghua Bing Li Xue Za Zhi. <javascript:AL_get(this,%20'jour',%20'Zhonghua%20Bing%20Li% *
for clinical gynecological disease. Gynecol. Obstet. Invest., 1990, № 29, p. 214 *
H <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Wang+H%22%5BAuthor%5D>., Chen G *
I., Bast R. The CA125 tumour-associated antigen: a review of the literature. *
Iwanari O., Miyako J., Date Y., Nakayama S., Kijima S., Moriyama M., Karino K., Endoh J., Kitao M. Clinical evaluations of the tumor marker sialyl SSEA-1 antigen for clinical gynecological disease. Gynecol. Obstet. Invest., 1990, № 29, p. 214 *
Jacobs I., Bast R. The CA125 tumour-associated antigen: a review of the literature. *
O., Miyako J., Date Y., Nakayama S., Kijima S., Moriyama M., Karino K., Endoh J., Kitao M. Clinical evaluations of the tumor marker sialyl SSEA-1 antigen *
Wang H., Chen G., Zhang B. Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma. Zhonghua Bing Li Xue Za Zhi. 2002, № 31, p. 391-395 *

Also Published As

Publication number Publication date
MD3244F1 (ro) 2007-02-28

Similar Documents

Publication Publication Date Title
HK1133680A1 (en) Nucleic acid enzymes and complexes and methods for their use
WO2005005462A3 (en) Blys antagonists and uses thereof
WO2007013950A3 (en) Combination therapy of her expressing tumors
WO2008027837A3 (en) Small molecule potentiator of hormonal therapy for breast cancer
IL190796A (en) Composition containing nucleic acid encoded by anti-osteoclastogenic protein
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
MX2012004258A (es) Inhibidores de la tirosina quinasa de bruton.
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
EP1991701A4 (en) COMPOSITIONS, KITS, AND METHODS FOR IDENTIFYING, EVALUATING, PREVENTING, AND TREATING CANCER
TW200630090A (en) Triazoles useful as inhibitors of protein kinases
WO2007051065A3 (en) Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
WO2009064444A9 (en) Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents
IL182423A0 (en) Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
WO2007011962A3 (en) Treatment of cancer
MX2007009807A (es) Agentes terapeuticos de aptameros utiles en el tratamiento de trastornos relacionados con el complemento.
MX2019005150A (es) Inhibidores de la tirosina-cinasa de bruton.
WO2006089087A9 (en) Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
SG155163A1 (en) Pharmacokinetically improved compounds
WO2008073899A3 (en) Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis
WO2007064945A3 (en) Cancer therapies and pharmaceutical compositions used therein
NO20072558L (no) Mitotiske kineseinhibitorer og fremgangsmater for anvendelse derav
MX2007011545A (es) Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr.
WO2008030883A3 (en) Treatment of cancer
WO2006028655A3 (en) Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
WO2006015079A3 (en) Erm family binding agents and their use in diagnosis and treatment of proliferative conditions

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees